Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment

Irene Tracey; Clifford J Woolf; Nick A Andrews

doi:10.1016/j.neuron.2019.02.019

Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment

Neuron. 2019 Mar 6;101(5):783-800. doi: 10.1016/j.neuron.2019.02.019.

Authors

Irene Tracey¹, Clifford J Woolf², Nick A Andrews³

Affiliations

¹ Nuffield Department of Clinical Neurosciences, University of Oxford, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK. Electronic address: irene.tracey@ndcn.ox.ac.uk.
² Kirby Neurobiology Center, Boston Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, 02115 MA, USA. Electronic address: clifford.woolf@childrens.harvard.edu.
³ Kirby Neurobiology Center, Boston Children's Hospital and Department of Neurobiology, Harvard Medical School, Boston, 02115 MA, USA.

Abstract

Pain is a subjective sensory experience that can, mostly, be reported but cannot be directly measured or quantified. Nevertheless, a suite of biomarkers related to mechanisms, neural activity, and susceptibility offer the possibility-especially when used in combination-to produce objective pain-related indicators with the specificity and sensitivity required for diagnosis and for evaluation of risk of developing pain and of analgesic efficacy. Such composite biomarkers will also provide improved understanding of pain pathophysiology.

Publication types

Research Support, N.I.H., Extramural
Review

MeSH terms

Analgesia / methods
Animals
Biomarkers / analysis
Humans
Pain / diagnosis*
Pain / etiology
Pain Management / methods*
Pain Measurement / methods*

Substances

Biomarkers

Abstract

Publication types

MeSH terms

Substances

Grants and funding